FREE CE: Treatment Advances in Multiple Sclerosis

Treatment Advances in Multiple Sclerosis

on-demand home study session

About the Faculty

Jacquelyn L. Bainbridge, BSPharm , PharmD, FCCP, MSCS, FAES Professor, Department of Clinical Pharmacy Skaggs School of Pharmacy and Pharmaceutical Sciences Professor, Department of Neurology Anschutz Medical Campus University of Colorado

Presentation: Treatment Advances in Multiple Sclerosis

Bio: Jacquelyn L. Bainbridge, BSPharm, PharmD, FCCP, MSCS, FAES, is a Professor at the University of Colorado Anschutz Medical Campus, where she holds joint appointments in the Skaggs School of Pharmacy and Pharmaceutical Sciences, Department of Clinical Pharmacy, and the Department of Neurology in the School of Medicine. Dr Bainbridge received her doctorate in pharmacy from the University of Colorado in Denver, where she subsequently completed a specialty residency in neurology. Dr Bainbridge is a Multiple Sclerosis Certified Specialist (MSCS) who is actively involved in clinical research in many areas of neurology, including epilepsy, multiple sclerosis (MS), Parkinson’s disease (PD), back pain and cannabis. She has reviewed and written several book chapters on MS, epilepsy, migraine, chronic pain, women’s issues, pharmacokinetics, and the practice of pharmacy. Dr Bainbridge is a frequent lecturer on topics of neurologic and pharmacologic interest, including chronic pain disorders, epilepsy, migraines, movement disorders, MS, neuroprotection, restless legs syndrome, Huntington’s disease and the administration of cannabis for therapeutic intent.

Disclosure: Jacquelyn L. Bainbridge does not have any relevant financial relationship(s) with ineligible companies (as defined by the Standards for Integrity and Independence).

Learning Objectives:

Briefly describe the pathophysiology of multiple sclerosis (MS) and its symptomatic impact on patients’ quality of life.
Explain the available pharmacologic treatment approaches for multiple sclerosis with regards to disease subtype, mechanism of action, effectiveness and adverse effects.
Identify emerging treatments and the potential impact on practice.
Explain how pharmacists can assist patients to address key barriers MS patients often face when managing their illness.

Fee

$0.00

CE Hours

1.25

CE Units

0.125

Activity Type

Knowledge

Support/Credits

Format

This course consists of an MP4 video and downloadable resources in PDF format. The video can be found by clicking on the tab below. After viewing the content, complete the online post-test and evaluation.

Continuing Education Credit Information

The University of Texas at Austin College of Pharmacy is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. This online activity is approved for 0.125 CEUs (1.25 contact hours) of continuing education credit. In order to receive 1.50 contact hours of CE credit, the participant must watch the video in its entirety, complete the online post-test, and complete the online evaluation. Please make sure NABP profile and date of birth (month/year) are correct under learner's profile in this system.

Funding Statement

This session is supproted in part through an educational grant from Novartis.

Review of Conflicts Policy: The UT Austin College of Pharmacy has a very strict policy to ensure against commercial conflicts of interest in CE programming. For this conference, the planning committee picks two committee members who have appropriate backgrounds to review content, and report any potential conflict of interest to the CPE Director. If conflict issues are discovered, they are addressed with speakers to make appropriate changes. Evaluations are collected from all participants with specific questions around the listed conflicts of commercial interest.

Pharmacy Practice Seminar • PPS

This program was recorded at the 69th Pharmacy Practice Seminar (PPS) annual conference that was held on September 26 & 27, 2020 (virtual seminar due to COVID-19). The seminar offers 15+ hours of CPE content. Please visit the PPS website here for more information about the event.

Treatment Advances in Multiple Sclerosis

Treatment Advances in Multiple Sclerosis

on-demand home study session

About the Faculty

Presentation: Treatment Advances in Multiple Sclerosis

Disclosure: Jacquelyn L. Bainbridge does not have any relevant financial relationship(s) with ineligible companies (as defined by the Standards for Integrity and Independence).

Learning Objectives:

Briefly describe the pathophysiology of multiple sclerosis (MS) and its symptomatic impact on patients’ quality of life.
Explain the available pharmacologic treatment approaches for multiple sclerosis with regards to disease subtype, mechanism of action, effectiveness and adverse effects.
Identify emerging treatments and the potential impact on practice.
Explain how pharmacists can assist patients to address key barriers MS patients often face when managing their illness.

Activity Number

0067-0000-21-145-H01-P/T

Release Date: Sep 25, 2021

Credit Expiration Date: Sep 1, 2024

CE Hours

1.25